Mirum Pharmaceuticals Statistics
Total Valuation
MIRM has a market cap or net worth of $1.11 billion. The enterprise value is $1.13 billion.
| Market Cap | 1.11B |
| Enterprise Value | 1.13B |
Important Dates
The next estimated earnings date is Thursday, May 2, 2024, after market close.
| Earnings Date | May 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MIRM has 46.61 million shares outstanding. The number of shares has increased by 20.31% in one year.
| Shares Outstanding | 46.61M |
| Shares Change (YoY) | +20.31% |
| Shares Change (QoQ) | +13.44% |
| Owned by Insiders (%) | 2.25% |
| Owned by Institutions (%) | 112.20% |
| Float | 35.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 104.17 |
| PS Ratio | 5.96 |
| Forward PS | 3.43 |
| PB Ratio | 4.46 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.07 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.45, with a Debt / Equity ratio of 1.24.
| Current Ratio | 4.45 |
| Quick Ratio | 4.07 |
| Debt / Equity | 1.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.75 |
Financial Efficiency
Return on equity (ROE) is -88.60% and return on invested capital (ROIC) is -19.60%.
| Return on Equity (ROE) | -88.60% |
| Return on Assets (ROA) | -31.50% |
| Return on Capital (ROIC) | -19.60% |
| Revenue Per Employee | $705,962 |
| Profits Per Employee | -$618,996 |
| Employee Count | 264 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 3.37 |
Taxes
In the past 12 months, MIRM has paid $991,000 in taxes.
| Income Tax | 991,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.48% in the last 52 weeks. The beta is 1.14, so MIRM's price volatility has been higher than the market average.
| Beta (1Y) | 1.14 |
| 52-Week Price Change | -8.48% |
| 50-Day Moving Average | 26.90 |
| 200-Day Moving Average | 28.16 |
| Relative Strength Index (RSI) | 35.97 |
| Average Volume (30 Days) | 508,272 |
Short Selling Information
The latest short interest is 8.16 million, so 17.51% of the outstanding shares have been sold short.
| Short Interest | 8.16M |
| Short Previous Month | 8.14M |
| Short % of Shares Out | 17.51% |
| Short % of Float | 23.19% |
| Short Ratio (days to cover) | 13.45 |
Income Statement
In the last 12 months, MIRM had revenue of $186.37 million and -$163.42 million in losses. Loss per share was -$4.00.
| Revenue | 186.37M |
| Gross Profit | 139.34M |
| Operating Income | -109.15M |
| Pretax Income | -162.42M |
| Net Income | -163.42M |
| EBITDA | -135.87M |
| EBIT | -147.32M |
| Loss Per Share | -$4.00 |
Balance Sheet
The company has $286.33 million in cash and $308.14 million in debt, giving a net cash position of -$21.82 million or -$0.47 per share.
| Cash & Cash Equivalents | 286.33M |
| Total Debt | 308.14M |
| Net Cash | -21.82M |
| Net Cash Per Share | -$0.47 |
| Equity / Book Value | 248.67M |
| Book Value Per Share | 5.33 |
| Working Capital | 300.48M |
Cash Flow
In the last 12 months, operating cash flow was -$70.94 million and capital expenditures -$109,000, giving a free cash flow of -$71.05 million.
| Operating Cash Flow | -70.94M |
| Capital Expenditures | -109,000 |
| Free Cash Flow | -71.05M |
| FCF Per Share | -$1.74 |
Margins
Gross margin is 74.76%, with operating and profit margins of -58.57% and -87.68%.
| Gross Margin | 74.76% |
| Operating Margin | -58.57% |
| Pretax Margin | -87.15% |
| Profit Margin | -87.68% |
| EBITDA Margin | -72.90% |
| EBIT Margin | -79.04% |
| FCF Margin | -38.12% |
Dividends & Yields
MIRM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.31% |
| Shareholder Yield | -20.31% |
| Earnings Yield | -14.72% |
| FCF Yield | -6.40% |
Analyst Forecast
The average price target for MIRM is $53.40, which is 124.28% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $53.40 |
| Price Target Difference | 124.28% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 36.60% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MIRM has an Altman Z-Score of 0.56 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.56 |
| Piotroski F-Score | 3 |